Header Logo

Connection

VALORY PAVLIK to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications VALORY PAVLIK has written about Drug Evaluation, Preclinical.
VALORY PAVLIK
Connection Strength
0.040
Drug Evaluation, Preclinical
  1. CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease. EBioMedicine. 2020 Sep; 59:102892.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.